Latest KPTI reports update at 2024-05-08: 2024-Q12023-Q42023-Q1
Karyopharm Therapeutics  logo
Karyopharm Therapeutics KPTI
$ 1.07 4.9%

Karyopharm Therapeutics Financial Statements 2011-2024 | KPTI

Annual Financial Statements Karyopharm Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

130 M 293 M 669 M 1.1 B 1 B 486 M 550 M 386 M 222 M 826 M 201 M - -

Shares

114 M 81.9 M 75.2 M 72 M 62 M 56.8 M 45.9 M 37.5 M 35.6 M 31.1 M 6.07 M - -

Historical Prices

1.14 3.58 8.9 15.2 16.1 8.47 11.8 10.3 6.22 26.5 34.9 - -

Net Income

-143 M -165 M -124 M -196 M -200 M -178 M -129 M -110 M -118 M -75.8 M -33.9 M -15.9 M -10.3 M

Revenue

146 M 157 M 210 M 108 M 40.9 M 30.3 M 1.6 M 154 K 250 K 229 K 387 K 634 K 152 K

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - 38.5 M - - - - - - - -

Operating Income

-130 M -142 M -98.3 M -172 M -189 M -180 M -131 M -111 M -119 M -75.8 M -34 M -15.9 M -10.3 M

Interest Expense

23.8 M 25 M 26 M 27.1 M 15.6 M 2.49 M -81 K 10 K -2 K 1 K 3 K 2 K -

EBITDA

-129 M -142 M -97.5 M -171 M -188 M -179 M -130 M -110 M -118 M -75.5 M -33.8 M -15.8 M -10.2 M

Operating Expenses

276 M 299 M 308 M 280 M 228 M 210 M 132 M 111 M 119 M 76.1 M 34.3 M - -

General and Administrative Expenses

132 M 145 M 144 M 126 M 105 M 48.8 M 24.9 M 23.9 M 21.6 M 15.9 M 5.88 M 2.43 M 1.84 M

All numbers in USD currency

Quarterly Income Statement Karyopharm Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

115 M 115 M 114 M 114 M 113 M 113 M 80.2 M 79.7 M 77.6 M 75.7 M 75.5 M 75.2 M 74.5 M 73.9 M 73.5 M 73.2 M 67.6 K 65.4 M 62.1 K 60.9 K 60.9 K 60.8 M 60.6 M 56.1 M 49.6 M 49.5 M 47.1 M 45.8 M 41.9 M 41.9 M 36.8 M 36 M 35.9 M 35.9 M 35.7 M 35.7 M 35.3 M 32.7 M 32.6 M 29.7 M 29.6 M 29.6 M 2.54 M 2.4 M 2.23 M 2.12 M -1.97 - - - - - -

Net Income

-37.4 M - -34.5 M -32.6 M -34.1 M - -36.3 M -49.1 M -41.4 M - -51.8 M -53.6 M -57.4 M - -53.5 M -46.4 M -52.9 M - -41.4 M -43.4 M -66.2 M -58.2 M -48.1 M -33.7 M -38.5 M -39 M -30.6 M -29.4 M -29.9 M -26.9 M -25.4 M -30.2 M -27.1 M -29 M -30.4 M -32.7 M -26.1 M -25.9 M -19.7 M -16.4 M -13.7 M -12.1 M -9.32 M -6.87 M -5.61 M -4.24 M -3.64 M -4.03 M -3.98 M - - - -

Revenue

33.1 M - 36 M 37.6 M 38.7 M - 36.1 M 39.7 M 47.7 M - 37.7 M 22.6 M 23.3 M - 21.3 M 33.5 M 18.1 M - 13.1 M 9.49 M 155 K 206 K 239 K 19.9 M 10 M 1.53 M 71 K 3 K 68 K 47 K 48 K 59 K - 25 K 75 K 150 K - 16 K 21 K 21 K 171 K 21 K 366 K 133 K 233 K 33 K 34 K 533 K 34 K - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - 1.01 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-33.8 M - -31.3 M -29.6 M -30.9 M - -30.8 M -42.9 M -34.6 M - -43.8 M -49 M -52.4 M - -47.1 M -40.3 M -47.4 M - -39.4 M -41.7 M -64.9 M -57.5 M -49.2 M -34.3 M -38.9 M -39.5 M -31.1 M -29.8 M -30.3 M -27.2 M -25.7 M -30.5 M -27.3 M -29.3 M -30.6 M -33 M -26.2 M -25.9 M -19.7 M -16.4 M -13.7 M -12.1 M -9.32 M -6.87 M -5.61 M -4.24 M -3.64 M -4.03 M -3.98 M - - - -

Interest Expense

5.88 M - 6.07 M 5.78 M 5.76 M - 6.11 M 6.31 M 6.68 M - 8.01 M 5 M 5.1 M - 6.8 M 6.76 M 6.51 M - 3.09 M 3.09 M 3 M -755 K -13 K 7 K -14 K 421 K 428 K 383 K 385 K 369 K 317 K 318 K 290 K 257 K 237 K 318 K 83 K 14 K 20 K 17 K 18 K 2 K - 1 K - - - 1 K 1 K - - - -

EBITDA

-33.7 M - - - -30.6 M - -30.3 M -42.9 M -34.4 M - -43.2 M -49 M -52.1 M - -46.4 M -39.8 M -47.1 M - -38.7 M -41.2 M -64.7 M -57.5 M -48.6 M -34 M -38.8 M -39.5 M -30.5 M -29.4 M -30.1 M -27.2 M -25.2 M -30.1 M -27.2 M -29.3 M -30.2 M -32.7 M -26 M -25.9 M -19.6 M -16.4 M -13.7 M -12.1 M -9.22 M -6.8 M -5.58 M -4.24 M -3.54 M -4.03 M -3.98 M - - - -

Operating Expenses

66.9 M - 67.3 M 67.2 M 69.6 M - 67 M 82.6 M 82.3 M - 81.5 M 71.6 M 75.6 M - 68.4 M 73.8 M 65.5 M - 52.6 M 51.2 M 65.1 M 57.7 M 49.4 M 54.2 M 48.9 M 41 M 31.1 M 29.8 M 30.3 M 27.2 M 25.8 M 30.5 M 27.3 M 29.3 M 30.7 M 33.2 M 26.2 M 26 M 19.8 M 16.5 M 13.9 M 12.2 M 9.32 M 7 M 5.84 M 4.27 M 3.67 M 4.57 M 4.02 M - - - -

General and Administrative Expenses

29.5 M - 30.8 M 34.5 M 35.9 M - 34.6 M 37.3 M 38.8 M - 35.1 M 36.5 M 37.6 M - 31 M 30.8 M 30.7 M - 25.3 M 24.7 M 27.1 M - 13 M 9.49 M 7.62 M - 5.82 M 6.64 M 6.26 M - 5.9 M 5.96 M 5.55 M - 4.76 M 6.16 M 5.4 M - 3.81 M 3.31 M 2.9 M - 1.58 M 943 K 879 K - 672 K - - - - - -

All numbers in USD currency